Abstract

The cereblon modulating agents (CMs) including lenalidomide, pomalidomide and CC-220 repurpose the Cul4-RBX1-DDB1-CRBN (CRL4CRBN) E3 ubiquitin ligase complex to induce the degradation of specific neomorphic substrates via polyubiquitination in conjunction with E2 ubiquitin-conjugating enzymes, which have until now remained elusive. Here we show that the ubiquitin-conjugating enzymes UBE2G1 and UBE2D3 cooperatively promote the K48-linked polyubiquitination of CRL4CRBN neomorphic substrates via a sequential ubiquitination mechanism. Blockade of UBE2G1 diminishes the ubiquitination and degradation of neomorphic substrates, and consequent antitumor activities elicited by all tested CMs. For example, UBE2G1 inactivation significantly attenuated the degradation of myeloma survival factors IKZF1 and IKZF3 induced by lenalidomide and pomalidomide, hence conferring drug resistance. UBE2G1-deficient myeloma cells, however, remained sensitive to a more potent IKZF1/3 degrader CC-220. Collectively, it will be of fundamental interest to explore if loss of UBE2G1 activity is linked to clinical resistance to drugs that hijack the CRL4CRBN to eliminate disease-driving proteins.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files

Article and author information

Author details

  1. Gang Lu

    PH TCoE, Celgene, San Diego, United States
    For correspondence
    glu@celgene.com
    Competing interests
    Gang Lu, Employee of Celgene.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2138-1522
  2. Stephanie Weng

    PH TCoE, Celgene, San Diego, United States
    Competing interests
    Stephanie Weng, Employee of Celgene.
  3. Mary Matyskiela

    Structral and Chemical Biology, Celgene, San Diego, United States
    Competing interests
    Mary Matyskiela, Employee of Celgene.
  4. Xinde Zheng

    PH TCoE, Celgene, San Diego, United States
    Competing interests
    Xinde Zheng, Employee of Celgene.
  5. Wei Fang

    Structral and Chemical Biology, Celgene, San Diego, United States
    Competing interests
    Wei Fang, Employee of Celgene.
  6. Scott Wood

    PH TCoE, Celgene, San Diego, United States
    Competing interests
    Scott Wood, Employee of Celgene.
  7. Christine Surka

    PH TCoE, Celgene, San Diego, United States
    Competing interests
    Christine Surka, Employee of Celgene.
  8. Reina Mizukoshi

    PH TCoE, Celgene, San Diego, United States
    Competing interests
    Reina Mizukoshi, Employee of Celgene.
  9. Chin-Chun Lu

    PH TCoE, Celgene, San Diego, United States
    Competing interests
    Chin-Chun Lu, Employee of Celgene.
  10. Derek Mendy

    PH TCoE, Celgene, San Diego, United States
    Competing interests
    Derek Mendy, Employee of Celgene.
  11. In Sock Jang

    Research Analytics, Celgene, San Diego, United States
    Competing interests
    In Sock Jang, Employee of Celgene.
  12. Kai Wang

    Research Analytics, Celgene, San Diego, United States
    Competing interests
    Kai Wang, Employee of Celgene.
  13. Mathieu Marella

    NCD - Exploratory Toxicology, Celgene, San Diego, United States
    Competing interests
    Mathieu Marella, Employee of Celgene.
  14. Suzana Couto

    NCD - Exploratory Toxicology, Celgene, San Diego, United States
    Competing interests
    Suzana Couto, Employee of Celgene.
  15. Brian Cathers

    PH TCoE, Celgene, San Diego, United States
    Competing interests
    Brian Cathers, Employee of Celgene.
  16. James Carmichael

    PH TCoE, Celgene, San Diego, United States
    Competing interests
    James Carmichael, Employee of Celgene.
  17. Philip Chamberlain

    Structral and Chemical Biology, Celgene, San Diego, United States
    Competing interests
    Philip Chamberlain, Employee of Celgene.
  18. Mark Rolfe

    PH TCoE, Celgene, San Diego, United States
    Competing interests
    Mark Rolfe, Employee of Celgene.

Funding

No external funding was received for this work

Reviewing Editor

  1. Wade Harper, Harvard Medical School, United States

Version history

  1. Received: August 10, 2018
  2. Accepted: September 19, 2018
  3. Accepted Manuscript published: September 20, 2018 (version 1)
  4. Version of Record published: October 12, 2018 (version 2)

Copyright

© 2018, Lu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,870
    views
  • 816
    downloads
  • 60
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Gang Lu
  2. Stephanie Weng
  3. Mary Matyskiela
  4. Xinde Zheng
  5. Wei Fang
  6. Scott Wood
  7. Christine Surka
  8. Reina Mizukoshi
  9. Chin-Chun Lu
  10. Derek Mendy
  11. In Sock Jang
  12. Kai Wang
  13. Mathieu Marella
  14. Suzana Couto
  15. Brian Cathers
  16. James Carmichael
  17. Philip Chamberlain
  18. Mark Rolfe
(2018)
UBE2G1 governs the destruction of cereblon neomorphic substrates
eLife 7:e40958.
https://doi.org/10.7554/eLife.40958

Share this article

https://doi.org/10.7554/eLife.40958

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Ya-Juan Wang, Xiao-Jing Di ... Ting-Wei Mu
    Research Article

    Protein homeostasis (proteostasis) deficiency is an important contributing factor to neurological and metabolic diseases. However, how the proteostasis network orchestrates the folding and assembly of multi-subunit membrane proteins is poorly understood. Previous proteomics studies identified Hsp47 (Gene: SERPINH1), a heat shock protein in the endoplasmic reticulum lumen, as the most enriched interacting chaperone for gamma-aminobutyric type A (GABAA) receptors. Here, we show that Hsp47 enhances the functional surface expression of GABAA receptors in rat neurons and human HEK293T cells. Furthermore, molecular mechanism study demonstrates that Hsp47 acts after BiP (Gene: HSPA5) and preferentially binds the folded conformation of GABAA receptors without inducing the unfolded protein response in HEK293T cells. Therefore, Hsp47 promotes the subunit-subunit interaction, the receptor assembly process, and the anterograde trafficking of GABAA receptors. Overexpressing Hsp47 is sufficient to correct the surface expression and function of epilepsy-associated GABAA receptor variants in HEK293T cells. Hsp47 also promotes the surface trafficking of other Cys-loop receptors, including nicotinic acetylcholine receptors and serotonin type 3 receptors in HEK293T cells. Therefore, in addition to its known function as a collagen chaperone, this work establishes that Hsp47 plays a critical and general role in the maturation of multi-subunit Cys-loop neuroreceptors.

    1. Biochemistry and Chemical Biology
    Hao Wang, Chen Ye ... Yan Li
    Research Article

    Bacterial exonuclease III (ExoIII), widely acknowledged for specifically targeting double-stranded DNA (dsDNA), has been documented as a DNA repair-associated nuclease with apurinic/apyrimidinic (AP)-endonuclease and 3′→5′ exonuclease activities. Due to these enzymatic properties, ExoIII has been broadly applied in molecular biosensors. Here, we demonstrate that ExoIII (Escherichia coli) possesses highly active enzymatic activities on ssDNA. By using a range of ssDNA fluorescence-quenching reporters and fluorophore-labeled probes coupled with mass spectrometry analysis, we found ExoIII cleaved the ssDNA at 5′-bond of phosphodiester from 3′ to 5′ end by both exonuclease and endonuclease activities. Additional point mutation analysis identified the critical residues for the ssDNase action of ExoIII and suggested the activity shared the same active center with the dsDNA-targeted activities of ExoIII. Notably, ExoIII could also digest the dsDNA structures containing 3′-end ssDNA. Considering most ExoIII-assisted molecular biosensors require the involvement of single-stranded DNA (ssDNA) or nucleic acid aptamer containing ssDNA, the activity will lead to low efficiency or false positive outcome. Our study revealed the multi-enzymatic activity and the underlying molecular mechanism of ExoIII on ssDNA, illuminating novel insights for understanding its biological roles in DNA repair and the rational design of ExoIII-ssDNA involved diagnostics.